L’Health Technology Assessment come strumento value-based per la valutazione delle tecnologie sanitarie. Reassessment del vaccino antinfluenzale quadrivalente da coltura cellulare: Flucelvax Tetra® 2.0

Saved in:
Bibliographic Details
Published inJournal of preventive medicine and hygiene Vol. 63; no. 4 Suppl 1; pp. E1 - E140
Main Authors CALABRÒ, GIOVANNA ELISA, BOCCALINI, SARA, BECHINI, ANGELA, PANATTO, DONATELLA, DOMNICH, ALEXANDER, LAI, PIERO LUIGI, AMICIZIA, DANIELA, RIZZO, CATERINA, PUGLIESE, ANDREA, DI PIETRO, MARIA LUISA, ZANELLA, BEATRICE, PARENTE, FLAVIO, TROMBETTA, CARLO SIMONE, SARACENO, GIOVANNI, SOTTILE, SARA, ABREHA, FASIKA MOLLA, GIACCHETTA, IRENE, PROPERZI, SARA, SANTOLINI, GIULIA, D’AMBROSIO, FLORIANA, MAIDA, ADA, SCARDIGNO, ANNA, LA GATTA, EMANUELE, PETRELLA, LUIGI, BONANNI, PAOLO, DE WAURE, CHIARA
Format Journal Article
LanguageEnglish
Published Pacini Editore srl 02.03.2023
Subjects
2.0
Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra
Online AccessGet full text

Cover

More Information
ISSN:1121-2233
2421-4248
DOI:10.15167/2421-4248/jpmh2022.63.4s1